Trials / Withdrawn
WithdrawnNCT03002740
Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation
Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation (Heart-BEAT): A Cohort Study Based on CPRD-HES Data
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In a population of patients with non-valvular atrial fibrillation (NVAF), and treated with oral anticoagulants (OAC) in routine clinical practice in England, this study will describe patients treated with each OAC, and to estimate and compare event rates of treatment discontinuation, bleeding, and healthcare resource utilisation (HCRU) across OAC treatments.
Conditions
Timeline
- Start date
- 2016-01-31
- Primary completion
- 2018-08-31
- Completion
- 2018-08-31
- First posted
- 2016-12-26
- Last updated
- 2018-10-10
Source: ClinicalTrials.gov record NCT03002740. Inclusion in this directory is not an endorsement.